Cite
HARVARD Citation
Nagler, M. et al. (2017). Long‐term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis. pp. 2165-2175. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nagler, M. et al. (2017). Long‐term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis. pp. 2165-2175. [Online].